Long-acting GHRH analogue incorporating DAC technology.
Studied in endocrine and receptor-signaling models.
Extended half-life compared to Mod GRF(1-29).
For research only. Not for human consumption.
Researchers working with CJC-1295 with DAC (Drug Affinity Complex) often focus on its extended-duration profile and its relevance to growth-hormone–axis studies. In laboratory environments, this peptide is commonly used for projects such as:
Investigating long-acting GHRH analogues and their interaction with the GH secretagogue pathway
Examining how DAC technology influences peptide half-life, binding behavior, and sustained release in controlled models
Mapping endocrine signaling dynamics, including pulsatile GH patterns, receptor engagement, and downstream transcriptional activity
Studying pharmacokinetic distinctions between CJC-1295 with DAC and non-DAC GHRH analogues
Evaluating peptide-driven effects on cellular growth, metabolic regulation, or tissue adaptation in vitro or in animal research
Our CJC-1295 with DAC is produced as a high-purity laboratory reagent intended for rigorous experimental use. Researchers who buy CJC-1295 with DAC appreciate its stability, consistency, and suitability for long-duration endocrine and peptide-modulation studies requiring precise control.
This material is intended solely for scientific research and must not be used for any medical, therapeutic, or diagnostic purpose.
For research use only. Not for human consumption.
Not a researcher? Exit
